Interoperability of RTN1A in dendrite dynamics and immune functions in human Langerhans cells.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
12 10 2022
Historique:
received: 25 05 2022
accepted: 09 09 2022
entrez: 12 10 2022
pubmed: 13 10 2022
medline: 15 10 2022
Statut: epublish

Résumé

Skin is an active immune organ where professional antigen-presenting cells such as epidermal Langerhans cells (LCs) link innate and adaptive immune responses. While Reticulon 1A (RTN1A) was recently identified in LCs and dendritic cells in cutaneous and lymphoid tissues of humans and mice, its function is still unclear. Here, we studied the involvement of this protein in cytoskeletal remodeling and immune responses toward pathogens by stimulation of Toll-like receptors (TLRs) in resident LCs (rLCs) and emigrated LCs (eLCs) in human epidermis ex vivo and in a transgenic THP-1 RTN1A

Identifiants

pubmed: 36223176
doi: 10.7554/eLife.80578
pii: 80578
pmc: PMC9555864
doi:
pii:

Substances chimiques

Lipoproteins 0
Nerve Tissue Proteins 0
RTN1 protein, human 0
Toll-Like Receptor 1 0
Toll-Like Receptor 2 0
Toll-Like Receptor 7 0
Toll-Like Receptors 0
RNA 63231-63-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2022, Cichoń, Cichoń et al.

Déclaration de conflit d'intérêts

MC, KP, JL, LW, CS, PS, AE No competing interests declared

Références

Chembiochem. 2017 Jul 4;18(13):1338-1345
pubmed: 28489325
Front Immunol. 2019 May 14;10:1068
pubmed: 31139190
Immunity. 2007 Oct;27(4):610-24
pubmed: 17936032
J Invest Dermatol. 1983 Jul;81(1):46-8
pubmed: 6190951
Bioinformatics. 2011 Sep 1;27(17):2453-4
pubmed: 21727141
Cell Rep. 2017 Feb 7;18(6):1527-1542
pubmed: 28178528
Nat Methods. 2014 Oct;11(10):982-4
pubmed: 25264773
J Anat. 1953 Oct;87(4):387-406
pubmed: 13117757
J Invest Dermatol. 2011 Oct;131(10):2049-57
pubmed: 21677668
Cell. 2006 Feb 10;124(3):573-86
pubmed: 16469703
Blood. 2000 Dec 15;96(13):4276-84
pubmed: 11110702
Front Immunol. 2018 Feb 01;9:93
pubmed: 29449841
FASEB J. 2010 Jun;24(6):1838-51
pubmed: 20097873
Cell Death Dis. 2020 Feb 6;11(2):101
pubmed: 32029703
Nat Immunol. 2016 Oct;17(10):1159-66
pubmed: 27548435
Cell Death Differ. 2009 Jul;16(7):976-83
pubmed: 19444282
J Neurosci. 2014 Nov 26;34(48):15898-911
pubmed: 25429132
J Immunol. 2002 May 1;168(9):4361-71
pubmed: 11970978
Nature. 2000 Jan 27;403(6768):434-9
pubmed: 10667796
Trends Immunol. 2017 Nov;38(11):817-828
pubmed: 28720426
Nat Neurosci. 2017 Aug;20(8):1122-1132
pubmed: 28671692
Cell. 2007 Dec 14;131(6):1047-58
pubmed: 18083096
J Invest Dermatol. 1995 Jan;104(1):42-6
pubmed: 7528245
J Immunol. 2004 Sep 1;173(5):3051-61
pubmed: 15322165
J Immunol. 1998 Apr 15;160(8):3776-82
pubmed: 9558080
Methods Cell Biol. 2010;99:113-52
pubmed: 21035685
J Invest Dermatol. 2018 Jun;138(6):1318-1327
pubmed: 29369773
J Immunol. 1999 Dec 1;163(11):5989-93
pubmed: 10570286
Mol Ther. 2018 Aug 1;26(8):2019-2033
pubmed: 30078441
PLoS One. 2011;6(12):e29305
pubmed: 22216242
Nat Rev Immunol. 2019 Feb;19(2):89-103
pubmed: 30464294
Nat Immunol. 2014 Nov;15(11):1064-9
pubmed: 25240383
Nat Rev Immunol. 2008 May;8(5):362-71
pubmed: 18379575
Exp Dermatol. 2021 Sep;30(9):1279-1289
pubmed: 33797121
PLoS One. 2017 May 24;12(5):e0178220
pubmed: 28542462
J Invest Dermatol. 2010 Mar;130(3):755-62
pubmed: 19890348
Science. 2016 Sep 9;353(6304):
pubmed: 27492475
FASEB J. 2018 Aug;32(8):4132-4144
pubmed: 29509510
Front Neurosci. 2020 Jan 29;14:48
pubmed: 32116502
Nat Rev Immunol. 2015 Oct;15(10):643-54
pubmed: 26388332
Front Immunol. 2018 Jan 05;8:1941
pubmed: 29379502
J Immunol. 2013 Apr 1;190(7):3749-56
pubmed: 23460737
J Leukoc Biol. 2008 May;83(5):1118-27
pubmed: 18252867
J Invest Dermatol. 2021 Apr;141(4):939-942
pubmed: 32898509
FASEB J. 2013 Mar;27(3):978-90
pubmed: 23169771
Cell. 2018 Nov 15;175(5):1430-1442.e17
pubmed: 30454650
Science. 2010 Feb 5;327(5966):656-61
pubmed: 20133564
Front Cell Dev Biol. 2021 Jan 15;8:608876
pubmed: 33542915
Immunity. 2010 Mar 26;32(3):305-15
pubmed: 20346772
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Exp Cell Res. 2007 Jun 10;313(10):2050-62
pubmed: 17512929
Cold Spring Harb Perspect Biol. 2011 May 01;3(5):
pubmed: 21441596
J Biol Chem. 2004 Dec 31;279(53):55315-23
pubmed: 15496415
J Biol Chem. 1978 Sep 10;253(17):5892-4
pubmed: 28319
Dev Cell. 2021 Jan 11;56(1):52-66.e7
pubmed: 33434526
Nat Commun. 2021 Jun 18;12(1):3799
pubmed: 34145230
J Immunol. 2006 Dec 1;177(11):7959-67
pubmed: 17114468
Front Immunol. 2021 Jun 21;12:679458
pubmed: 34234780
Nat Rev Immunol. 2005 Aug;5(8):617-28
pubmed: 16056255
Sci Rep. 2017 Jul 21;7(1):6145
pubmed: 28733667
J Clin Invest. 2004 Mar;113(5):701-8
pubmed: 14991068
J Immunol. 2009 Apr 15;182(8):5041-51
pubmed: 19342684
Nano Lett. 2017 Nov 8;17(11):6941-6948
pubmed: 29022351
Immunity. 2011 May 27;34(5):637-50
pubmed: 21616434
J Leukoc Biol. 1999 Jul;66(1):33-9
pubmed: 10410987
PLoS One. 2015 Apr 02;10(3):e0119532
pubmed: 25835294
PLoS One. 2010 Aug 25;5(8):e12410
pubmed: 20811642
J Invest Dermatol. 2013 May;133(5):1240-9
pubmed: 23389393
Nat Immunol. 2004 Feb;5(2):190-8
pubmed: 14716310
Nat Commun. 2019 Feb 4;10(1):568
pubmed: 30718476
Nature. 2000 Jan 27;403(6768):439-44
pubmed: 10667797
Nat Cell Biol. 2021 May;23(5):476-484
pubmed: 33958758
Proc Natl Acad Sci U S A. 2012 Apr 10;109(15):E889-97
pubmed: 22411813
Nat Rev Mol Cell Biol. 2003 Jul;4(7):517-29
pubmed: 12838335
Elife. 2017 Jun 15;6:
pubmed: 28617241
Nature. 2001 Jan 18;409(6818):341-6
pubmed: 11201742
J Immunol. 2007 Feb 15;178(4):1986-90
pubmed: 17277101
J Allergy Clin Immunol. 2006 Jan;117(1):163-8
pubmed: 16387601
Immunity. 2021 Oct 12;54(10):2305-2320.e11
pubmed: 34508661
Mol Biol Cell. 1996 Jul;7(7):1025-41
pubmed: 8862518
J Biol Chem. 2003 Jan 3;278(1):37-47
pubmed: 12403782
BMC Res Notes. 2011 Jan 14;4:6
pubmed: 21235733
J Cell Sci. 1994 Sep;107 ( Pt 9):2403-16
pubmed: 7844160
J Immunol. 1989 Oct 15;143(8):2431-8
pubmed: 2571637
Biochim Biophys Acta. 2013 Jun;1833(6):1421-33
pubmed: 23454728
F1000Res. 2018 Nov 15;7:
pubmed: 30505430
Front Immunol. 2017 Nov 29;8:1676
pubmed: 29238347
Sci Rep. 2016 Dec 13;6:38655
pubmed: 27958302
Immunity. 2021 Oct 12;54(10):2188-2190
pubmed: 34644554
Cell. 2009 Aug 7;138(3):549-61
pubmed: 19665976

Auteurs

Małgorzata Anna Cichoń (MA)

Department of Dermatology, Medical University of Vienna, Vienna, Austria.

Karin Pfisterer (K)

Department of Dermatology, Medical University of Vienna, Vienna, Austria.

Judith Leitner (J)

Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.

Lena Wagner (L)

Department of Dermatology, Medical University of Vienna, Vienna, Austria.

Clement Staud (C)

Department of Plastic and Reconstructive Surgery, Medical University of Vienna, Vienna, Austria.

Peter Steinberger (P)

Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.

Adelheid Elbe-Bürger (A)

Department of Dermatology, Medical University of Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH